Taking a pharmaceutical meeting outside the U.S. can get complicated as you have to consider the meeting's host country's rules around payments to healthcare providers, as well as those of the HCPs' home countries. This article offers...
The Physician Payment Sunshine Act, Section 6002 of the Patient Protection and Affordable Care Act, which will require pharmaceutical companies to track and publicly report what they spend on healthcare providers, is still in limbo as of the f...
